Arsenic Trioxide
Generic Name: arsenic trioxide
Brand Names:
Arsenic Trioxide
Sterile injectable solution of arsenic trioxide. Available in 10 mL single-dose vials containing 10 mg arsenic trioxide at 1.0 mg/mL concentration in water for injection.
Overview
Sterile injectable solution of arsenic trioxide. Available in 10 mL single-dose vials containing 10 mg arsenic trioxide at 1.0 mg/mL concentration in water for injection.
Uses
Indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, characterized by t(15;17) translocation or PML/RAR-alpha gene expression.
Dosage
Induction: 0.15 mg/kg/day IV daily until bone marrow remission, maximum 60 days. Consolidation: 0.15 mg/kg/day IV daily for 25 doses over up to 5 weeks. Begin consolidation 3-6 weeks after induction completion.
Side Effects
Most common (over 30%): nausea, cough, fatigue, fever, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation.
Interactions
Avoid QT-prolonging drugs, electrolyte-altering medications, and hepatotoxic drugs. Monitor ECGs and electrolytes when concurrent use is necessary.
Warnings
BOXED WARNING: Differentiation Syndrome, Cardiac Conduction Abnormalities, and Encephalopathy including Wernicke encephalopathy. Hepatotoxicity monitoring required. Arsenic is a human carcinogen. Contraindicated in patients with hypersensitivity to arsenic.
Pregnancy
Can cause fetal harm. Animal studies show embryolethal and teratogenic effects. Use effective contraception. Do not breastfeed during treatment and 2 weeks after final dose.
Storage
After dilution, store no more than 24 hours at room temperature or 48 hours refrigerated. Hazardous drug - follow special handling and disposal procedures.
Frequently Asked Questions
What is Arsenic Trioxide used for?▼
Indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL) who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, characterized by t(15;17) translocation or PML/RAR-alpha gene expression.
What are the side effects of Arsenic Trioxide?▼
Most common (over 30%): nausea, cough, fatigue, fever, headache, abdominal pain, vomiting, tachycardia, diarrhea, dyspnea, hypokalemia, leukocytosis, hyperglycemia, hypomagnesemia, insomnia, dermatitis, edema, QTc prolongation.
Can I take Arsenic Trioxide during pregnancy?▼
Can cause fetal harm. Animal studies show embryolethal and teratogenic effects. Use effective contraception. Do not breastfeed during treatment and 2 weeks after final dose.
What are the important warnings for Arsenic Trioxide?▼
BOXED WARNING: Differentiation Syndrome, Cardiac Conduction Abnormalities, and Encephalopathy including Wernicke encephalopathy. Hepatotoxicity monitoring required. Arsenic is a human carcinogen. Contraindicated in patients with hypersensitivity to arsenic.
Related Medications
Colloidal Silver
colloidal silver
INDICATIONS: For temporary relief of raw sore feeling when coughing, great weakness of chest, affection of joints especially elbows and knees, micturition with burning.
Mecasermin
mecasermin
11 DESCRIPTION Mecasermin is a human insulin-like growth factor-1 (rhIGF-1) produced by recombinant DNA technology. IGF-1 consists of 70 amino acids in a single chain with three intramolecular disulfide bridges and a molecular weight of 7649 Da. The amino acid sequence of the product is identical to that of endogenous human IGF-1. The rhIGF-1 protein is synthesized in bacteria ( E. coli ) that have been modified by the addition of the gene for human IGF-1.
Arachis Hypogaea
arachis hypogaea
Dosage form: SOLUTION. Route: INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: PEANUT (.05 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.